INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,446 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
VE
Vanderjagt Katherine E.VP & Chief HR Officer
LZBLA-Z-BOY INC
Tax withholding
F$17K
408 sh
Jun 24, 2026Jun 26, 2026
Page 630 of 1737
← PrevNext →
traded Jun 24, 2026
+2d
SEC Form 4

Evidence

9
NF
Newman Andrea FischerDirector
SAROStandardAero, Inc.
Grant or award
A—
6,608 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
HS
Hendricks Dana SChief Financial Officer
PRAPROASSURANCE CORP
Disposition to issuer
D—
7,686 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
LY
Lee Carol YoungVP & Chief Information Officer
LZBLA-Z-BOY INC
Tax withholding
F$11K
262 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
WC
Ware Olivia CDirector
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
LL
Lyons-Williams LoriDirector
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
WS
Weingartner StefanDirector
SAROStandardAero, Inc.
Grant or award
A—
6,608 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
BR
Brady Todd R.Director
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
MP
McElhinney PaulDirector
SAROStandardAero, Inc.
Grant or award
A—
6,608 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
FD
Francis Robert DavidPres Healthcare Pro. Liability
PRAPROASSURANCE CORP
Disposition to issuer
D—
8,764 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
NG
Ng Wang Yu GaryDirector
NAGENiagen Bioscience, Inc.
Grant or award
A—
31.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
CA
Chakravarthy ArthiChief Legal Officer
ENVXEnovix Corp
Tax withholding
F$13K
2,221 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
DN
Dishart NoreenExecutive VP/Chief HR Officer
PRAPROASSURANCE CORP
Disposition to issuer
D—
9,175 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
SB
Schimmelpennink Evert B.Director
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
YW
YU Wing Tak WendyDirector
NAGENiagen Bioscience, Inc.
Grant or award
A—
31.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$302K
1,200 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
IA
Ignelzi Troy A.Director
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
GW
Gilliland Arthur WDirector
SKILSkillsoft Corp.
Option exercise
M—
6,250 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
HS
Hendricks Dana SChief Financial Officer
PRAPROASSURANCE CORP
Disposition to issuer
D—
23.7K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
SP
Silver Deirdre P.EVP, General Counsel
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A—
6,443 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
SR
Sundy Robert IIPresident, Retail
LZBLA-Z-BOY INC
Tax withholding
F$21K
497 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
FD
Francis Robert DavidPres Healthcare Pro. Liability
PRAPROASSURANCE CORP
Disposition to issuer
D—
11.8K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
WA
Weber AndrewEVP, Technology and Operations
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A—
8,680 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
KP
Kowalski Jessica PatriciaEVP and GM, Research
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A—
15.7K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
AM
Albright Craig MorrowEVP, Chief Financial Officer
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A—
12.8K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
KD
Krulik DouglasCAO and Interim CFO
PETSPETMED EXPRESS INC
Grant or award
A—
32.5K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
DN
Dishart NoreenExecutive VP/Chief HR Officer
PRAPROASSURANCE CORP
Disposition to issuer
D—
18.5K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
SH
Shahbazi HamedDirector
NAGENiagen Bioscience, Inc.
Grant or award
A—
31.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
CA
Cohen AnnDirector
NAGENiagen Bioscience, Inc.
Grant or award
A—
31.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
HS
Hendricks Dana SChief Financial Officer
PRAPROASSURANCE CORP
Disposition to issuer
D—
11.8K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
MJ
Moretti August JDirector
VANIVivani Medical, Inc.
Grant or award
A$44K
36.0K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
AM
Albright Craig MorrowEVP, Chief Financial Officer
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A—
20.0K sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
MD
Miralles Gines DiegoDirector
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
DN
Dishart NoreenExecutive VP/Chief HR Officer
PRAPROASSURANCE CORP
Disposition to issuer
D—
5,987 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
CC
Caridi ChristopherSVP, Chief Accounting Officer
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A—
2,054 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
FD
Francis Robert DavidPres Healthcare Pro. Liability
PRAPROASSURANCE CORP
Disposition to issuer
D—
23.7K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence

9
WP
Wierbicki PaulDirector, Chief Legal Officer
RSIRush Street Interactive, Inc.
Option exercise
M—
3,074 sh
Jun 25, 2026Jun 26, 2026
traded Jun 25, 2026
+1dSEC Form 4

Evidence

9
PK
Patrick KristinDirector
NAGENiagen Bioscience, Inc.
Grant or award
A—
31.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

9
LE
Luebke Taylor EdwardSVP and CFO
LZBLA-Z-BOY INC
Tax withholding
F$6,654
159 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC Form 4

Evidence

8
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
3,000 sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC Form 4

Evidence